Association in  cis  of β + ‐thalassemia and hemoglobin S | Zendy

Baklouti Faouzi | Zendy; Francina Alain | Zendy; Dorléac Evelyne | Zendy; Richard Georges | Zendy; Rosenberg Daniel | Zendy; Godet Jacqueline | Zendy; Delaunay Jean | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Association in cis of β + ‐thalassemia and hemoglobin S

Author(s) -

Baklouti Faouzi,

Francina Alain,

Dorléac Evelyne,

Richard Georges,

Rosenberg Daniel,

Godet Jacqueline,

Delaunay Jean

Publication year - 1987

Publication title -

american journal of hematology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.456

H-Index - 105

eISSN - 1096-8652

pISSN - 0361-8609

DOI - 10.1002/ajh.2830260305

Subject(s) - microcytosis , thalassemia , amino acid substitution , hemoglobin , hemoglobin variants , genetics , amino acid , mutation , chemistry , restriction enzyme , biology , microbiology and biotechnology , biochemistry , medicine , dna , anemia , gene , iron deficiency

A Moroccan woman was investigated because of a typical β‐thalassemia trait associated with a low‐percentage (11%) hemoglobin (Hb) variant. The β‐thalassemia trait was manifested by a microcytosis, a high HbA 2 (above 6%), and an increase of the α/β biosynthetic ratio (1.31). The variant was identified to HbS by amino acid analysis of the abnormal peptide (β T1) and by DNA mapping with Sau I (Mst II) restriction endonuclease. No additional amino acid substitution was recorded in the β s ‐chain. The reduction of β‐globin synthesis occurred exclusively at the expense of the β s ‐chain. These results are consistent with the existence of a β s mutation and a β + ‐thalassemia in cis .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research